Exposing Hodgkin-Reed-Sternberg cells

被引：8

作者：

Steidl, Christian ^{[1
]}

机构：

[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

来源：

BLOOD | 2017年 / 129卷 / 01期

关键词：

LYMPHOMA;

D O I：

10.1182/blood-2016-11-746701

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：6 / 7

页数：2

共 9 条

[1] Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma [J].

Du, Jing ;

Neuenschwander, Martin ;

Yu, Yong ;

Daebritz, J. Henry M. ;

Neuendorff, Nina-Rosa ;

Schleich, Kolja ;

Bittner, Aitomi ;

Milanovic, Maja ;

Beuster, Gregor ;

Radetzki, Silke ;

Specker, Edgar ;

Reimann, Maurice ;

Rosenbauer, Frank ;

Mathas, Stephan ;

Lohneis, Philipp ;

Hummel, Michael ;

Doerken, Bernd ;

von Kries, Jens Peter ;

Lee, Soyoung ;

Schmitt, Clemens A. .

BLOOD, 2017, 129 (01) :71-81

[2] Ibrutinib in Refractory Classic Hodgkin's Lymphoma [J].

Hamadani, Mehdi ;

Balasubramanian, Sriram ;

Hari, Parameswaran N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (14) :1381-1382

[3]

Küppers R, 2012, J CLIN INVEST, V122, P3439, DOI [10.1172/JCI6124.5, 10.1172/JCI61245]

[4] The biology of Hodgkin's lymphoma [J].

Kueppers, Ralf .

NATURE REVIEWS CANCER, 2009, 9 (01) :15-27

[5] Inhibition of NF-κB essentially contributes to arsenic-induced apoptosis [J].

Mathas, S ;

Lietz, A ;

Janz, M ;

Hinz, M ;

Jundt, F ;

Scheidereit, C ;

Bommert, K ;

Dörken, B .

BLOOD, 2003, 102 (03) :1028-1034

[6] Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment [J].

Steidl, Christian ;

Connors, Joseph M. ;

Gascoyne, Randy D. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) :1812-1826

[7] Acute promyelocytic leukemia: What is the new standard of care? [J].

Watts, Justin M. ;

Tallman, Martin S. .

BLOOD REVIEWS, 2014, 28 (05) :205-212

[8] Novel agents in the treatment of Hodgkin lymphoma: Biological basis and clinical results [J].

Younes, Anas ;

Ansell, Stephen M. .

SEMINARS IN HEMATOLOGY, 2016, 53 (03) :186-189

[9] Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma [J].

Younes, Anas ;

Oki, Yasuhiro ;

McLaughlin, Peter ;

Copeland, Amanda R. ;

Goy, Andre ;

Pro, Barbara ;

Feng, Lei ;

Yuan, Ying ;

Chuang, Hubert H. ;

Macapinlac, Homer A. ;

Hagemeister, Fredrick ;

Romaguera, Jorge ;

Samaniego, Felipe ;

Fanale, Michelle A. ;

Dabaja, Bouthaina Shbib ;

Rodriguez, Maria A. ;

Dang, Nam ;

Kwak, Larry W. ;

Neelapu, Sattva S. ;

Fayad, Luis E. .

BLOOD, 2012, 119 (18) :4123-4128

← 1 →